2C-O-4, also known as 4-isopropoxy-2,5-dimethoxyphenethylamine, is a phenethylamine of the 2C family.[1] It is also a positional isomer of isoproscaline and was probably first synthesized by Alexander Shulgin.[1] It produces hallucinogenic or psychedelic effects.[1] Because of the low potency of 2C-O-4, and the inactivity of 2C-O, Shulgin felt that the 2C-O series would not be an exciting area for research, and did not pursue any further analogues.[1]
Use and effects
Little is known about the psychopharmacological effects of 2C-O-4.[1] Based on the one report available in his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists 2C-O-4's dose as being greater than 60 mg orally.[1] At this dose, threshold psychoactive effects occurred.[1] These included awareness of something in the front part of the head, yawning, physiological changes, and a general exhilaration and excitement.[1] The effects lasted "a few hours" and were rated as a "plus-one" on the Shulgin Rating Scale.[1] The drug was regarded as remaining to be fully explored.[1]
Interactions
Pharmacology
Pharmacodynamics
The pharmacology of 2C-O-4 analogues has been studied.[2]
Chemistry
2C-O-4 is in a class of compounds commonly known as phenethylamines, and the systematic chemical name is 2-(4-isopropoxy-2,5-dimethoxyphenyl)ethanamine.[1]
Synthesis
The chemical synthesis of 2C-O-4 has been described.[1]
History
2C-O-4 was first described in the literature by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.[1]
Society and culture
Legal status
Canada
As of October 31, 2016, 2C-O-4 is a controlled substance (Schedule III) in Canada.[3]
United States
2C-O-4 is unscheduled and unregulated in the United States; however, because of its close similarity in structure and effects to mescaline and 2C-T-7, possession and sale of 2C-O-4 may be subject to prosecution under the Federal Analog Act.
See also
References
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. 2C-O-4 Entry in PiHKAL
- ↑ Kolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2019). "Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines". Front Pharmacol. 10: 1423. doi:10.3389/fphar.2019.01423. PMC 6893898. PMID 31849671.
- ↑ "Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". 4 May 2016.
External links
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||